SWITCH TO A FIXED-DOSE COMBINATION THERAPY WITH TELMISARTAN AND AMLODIPINE PROVIDES SIGNIFICANT BLOOD PRESSURE REDUCTION AND CONTROL IN PATIENTS NOT ADEQUATELY CONTROLLED WITH AMLODIPINE 10 MG

被引：0

作者：

Neldam, S. ^{[1
]}

Edwards, C. ^{[2
]}

机构：

[1] Rodovre Centrum, Rodovre, Denmark

[2] Boehringer Ingelheim Ireland Ltd, Dublin, Ireland

来源：

JOURNAL OF HYPERTENSION | 2009年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：S277 / S277

页数：1

共 50 条

[41] Effect of a fixed dose combination amlodipine/valsartan on central aortic blood pressure in uncontrolled essential hypertension with amlodipine 5mg: The EXPLOR study
Boutouvrie, P.
Laurent, S.
Achouba, A.
JOURNAL OF HYPERTENSION, 2008, 26 : S170 - S170
[42] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension (vol 30 pg 1086, 2013)
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2014, 31 (04) : 472 - 472
[43] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension (vol 30, pg 1086, 2013)
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2014, 31 (02) : 243 - 243
[44] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension (vol 30, pg 1086, 2013)
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2015, 32 (02) : 184 - 185
[45] Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/ Indapamide, and Telmisartan/Amlodipine/ Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiovascular Risk: A Real-world Observational Study
Samajdar, Shambo samrat
Mukherjee, Shatavisa
Tripathi, Santanu Kumar
Pal, Jyotirmoy
Joshi, Shashank
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (01) : OC22 - OC25
[46] Daytime Systolic Ambulatory Blood Pressure With a Direct Switch Between Candesartan Monotherapy and the Fixed-Dose Combination Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL-1)
Zemmrich, Claudia
Lueders, Stephan
Gansz, Andrea
Sturm, Claus-Dieter
Fimmers, Rolf
Nadal, Jennifer
Schmieder, Roland E.
Schrader, Joachim
Bramlage, Peter
JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (11): : 815 - 819
[47] Evaluation of Blood Pressure Reduction Response and Responder Characteristics to Fixed-Dose Combination Treatment of Amlodipine and Losartan: A Post Hoc Analysis of Pooled Clinical Trials
Unniachan, Sreevalsa
Wu, David
Rajagopalan, Srinivasan
Hanson, Mary E.
Fujita, Kenji P.
JOURNAL OF CLINICAL HYPERTENSION, 2014, 16 (09): : 671 - 677
[48] Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone
Grzegorz Bilo
Winfried Koch
Satoshi Hoshide
Gianfranco Parati
Hypertension Research, 2014, 37 : 836 - 844
[49] Effective and safe reduction of blood pressure by the combination of amlodipine 5/valsartan 160mg in hypertensive patients not controlled by amlodipine 5 mg or felodipine 5 mg - The express-M trial
Brachmann, J.
Handrock, R.
Klebs, S.
JOURNAL OF HYPERTENSION, 2007, 25 : S385 - S386
[50] Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone
Bilo, Grzegorz
Koch, Winfried
Hoshide, Satoshi
Parati, Gianfranco
HYPERTENSION RESEARCH, 2014, 37 (09) : 836 - 844

← 1 2 3 4 5 →